MCWardMD Profile Banner
Matthew Ward Profile
Matthew Ward

@MCWardMD

Followers
2K
Following
3K
Media
189
Statuses
2K

Radiation Oncologist at @LevineCancer @AtriumHealth and Southeast #radonc (SERO). #hncsm, #pcsm, #lcsm, #biostats. Tweets=my opinion.

Charlotte, NC
Joined October 2015
Don't wanna be here? Send us removal request.
@MCWardMD
Matthew Ward
4 years
Stoked to receive my copy of ECRO, 2nd Edition! Each chapter revised & updated with multiple new chapters. Back in 2015, I wasn't sure we'd see this day! Thanks to all contributors and @SarahSittenfeld @RTendulkarMD @videtig for heading it up! See here:
Tweet media one
14
22
149
@MCWardMD
Matthew Ward
4 days
RT @AlexSherryMD: Does the addition of MDT to standard of care continuous ADT improve outcomes for oligomet prostate ca?. Happy to share th….
0
74
0
@MCWardMD
Matthew Ward
10 days
RT @Xristodouleas: Let me start by clearly stating: some of my best friends are Urologists. 🙂. But: I worry the response to the SEMS RPLND….
0
11
0
@MCWardMD
Matthew Ward
1 month
RT @iaeaorg: In high-income countries, 90% of cancer patients have access to radiotherapy; in middle-income countries it’s 60%; but in low-….
0
25
0
@MCWardMD
Matthew Ward
2 months
RT @JJCaudell: Rising PGY-5s and anyone interested, we have a 5th HN rad onc position @MoffittNews. If interested in joining a busy team,….
0
15
0
@MCWardMD
Matthew Ward
2 months
Happy that @LevineCancer could contribute to this novel study! Congrats to all and to Richard White for the coauthor. @Dr_LHG.
@DrYukselUrun
Yüksel Ürün
2 months
No surgery. No recurrence. In this phase 2 trial (n=50), selected patients with HER2+ or TNBC who had pCR after neoadjuvant therapy skipped breast surgery. With 5 years of follow-up:.🟡0% ipsilateral recurrence.🟡100% DFS & OS.A bold signal toward surgical de-escalation. Looking
Tweet media one
0
0
12
@MCWardMD
Matthew Ward
2 months
RT @DrSpratticus: X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere. The purpose o….
0
146
0
@MCWardMD
Matthew Ward
2 months
It was a pleasure working with an all-star team to update the former ACR (now @RadiumSociety) "Appropriate Use" guideline on sinonasal cancer #radonc #hncsm @HeadNeckMD @MargalitMd
Tweet media one
0
3
27
@MCWardMD
Matthew Ward
3 months
RT @drjefstathiou: 💡 Proton therapy remains an effective option for localized prostate cancer, but could some patients benefit more than ot….
0
2
0
@MCWardMD
Matthew Ward
3 months
RT @piet_ost: POTEN-C: Nerve-sparing SAbR (NV-SAbR) in PCa: @ndesai2005 #ESTRO25. Results at 3mo.🛡️🧠 Less nerve damage.⬇️🧻 Fewer bowel/blad….
0
38
0
@MCWardMD
Matthew Ward
4 months
RT @NRGonc: No April Fool's joke . it is #HeadAndNeckCancerAwarenessMonth. This includes cancers in the larynx, throat, lips, mouth, nose….
0
3
0
@MCWardMD
Matthew Ward
5 months
RT @PBlanchardMD: Hot of the press @IJROBP: Role of SABR in oligometastatic head and neck cancer: a GORTEC randomized trial . Full text her….
0
65
0
@MCWardMD
Matthew Ward
5 months
Our group has an employed opportunity for a Radiation Oncologist available - happy to discuss details with anyone interested!.
0
0
3
@MCWardMD
Matthew Ward
6 months
It’s an honor to care for patients with the support of outstanding organizations like @LevineCancer and @Panthers.
@Panthers
Carolina Panthers
6 months
Today, we donated a Keep Pounding Drum to the Proton & Advanced Radiation Center at Atrium Health Levine Cancer, honoring the journey of current patient Shannon Myers. After completing proton beam therapy in December, Shannon continues to exemplify the true spirit of Keep
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
1
13
@MCWardMD
Matthew Ward
7 months
RT @DavidSherMD: I don't treat HCC, but RFA is clearly inferior to SBRT in this study. The local control (75%) with RFA is poor in absolu….
0
21
0
@MCWardMD
Matthew Ward
8 months
RT @5_utr: 🚨 🚨 RCT of SBRT vs RFA for recurrent small HCC. HR for local progression free survival a whopping 0.45 (0.95 CI 0.24-0.87) with….
Tweet card summary image
ascopubs.org
PURPOSETo assess the efficacy and safety of radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) in treating recurrent small hepatocellular carcinoma (HCC).METHODSIn this trial,...
0
31
0
@MCWardMD
Matthew Ward
8 months
RT @5_utr: ❗️ SUPREMO abstract now up. For pN1 patients: overall survival HR 0.82 (0.63-1.05) in favor of CWI. Authors conclusions: “No imp….
0
15
0
@MCWardMD
Matthew Ward
8 months
Why is radiation held to a higher standard than drugs??.
@NiuSanford
Dr. Nina Niu Sanford
8 months
We also stratified by Stage and trial Phase. Even for Stage 4 cancer, 100% of RT trials in prostate/breast/lung/GI had primary endpoint OS vs lower in systemic (20% breast, 23% lung, 32% GI, prostate was 67%). 5/12
Tweet media one
1
6
22
@MCWardMD
Matthew Ward
8 months
RT @LondonProstate1: @TylerSbrt @FocalSociety @UkFocal FDA has not, to my knowledge, granted a ‘cancer treatment indication’ for any focal….
0
3
0